We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRI icon
1126
Herc Holdings
HRI
$4.97B
$238K ﹤0.01%
1,783
+62
+4% +$9.16K
CRC icon
1127
California Resources
CRC
$4.63B
$236K ﹤0.01%
4,426
+171
+4% +$8.72K
BOX icon
1128
Box
BOX
$4.93B
$235K ﹤0.01%
8,899
+340
+4% +$9.06K
ICUI icon
1129
ICU Medical
ICUI
$4.37B
$235K ﹤0.01%
1,977
+112
+6% +$11.8K
NOG icon
1130
Northern Oil and Gas
NOG
$2.72B
$234K ﹤0.01%
6,294
+977
+18% +$39.2K
KTB icon
1131
Kontoor Brands
KTB
$4.24B
$233K ﹤0.01%
3,529
+128
+4% +$8.37K
NVS icon
1132
Novartis
NVS
$291B
$233K ﹤0.01%
+2,192
New +$220K
WK icon
1133
Workiva
WK
$4.31B
$233K ﹤0.01%
3,195
+182
+6% +$14.3K
AEO icon
1134
American Eagle Outfitters
AEO
$2.86B
$232K ﹤0.01%
11,603
+479
+4% +$10.9K
CLSK icon
1135
CleanSpark
CLSK
$3.05B
$230K ﹤0.01%
14,449
+2,319
+19% +$39K
PATK icon
1136
Patrick Industries
PATK
$2.65B
$230K ﹤0.01%
3,177
+124
+4% +$9.08K
SKY icon
1137
Champion Homes
SKY
$4.89B
$230K ﹤0.01%
3,388
+113
+3% +$8.46K
OTTR icon
1138
Otter Tail
OTTR
$3.83B
$229K ﹤0.01%
2,613
+105
+4% +$9.19K
JWN
1139
DELISTED
Nordstrom
JWN
$227K ﹤0.01%
10,710
-1,460
-12% -$29.8K
STRL icon
1140
Sterling Infrastructure
STRL
$14.7B
$227K ﹤0.01%
1,914
+93
+5% +$10.6K
QTWO icon
1141
Q2 Holdings
QTWO
$4.1B
$225K ﹤0.01%
+3,733
New +$214K
CBZ icon
1142
CBIZ
CBZ
$2.96B
$225K ﹤0.01%
3,039
+142
+5% +$10.7K
VNOM icon
1143
Viper Energy
VNOM
$15.9B
$225K ﹤0.01%
+5,995
New +$228K
BBIO icon
1144
BridgeBio Pharma
BBIO
$15.1B
$225K ﹤0.01%
8,871
+1,803
+26% +$49.3K
PI icon
1145
Impinj
PI
$5.2B
$224K ﹤0.01%
+1,431
New +$213K
HP icon
1146
Helmerich & Payne
HP
$4.25B
$223K ﹤0.01%
6,163
+240
+4% +$9.23K
TPH
1147
DELISTED
Tri Pointe Homes
TPH
$222K ﹤0.01%
5,972
+97
+2% +$3.65K
ALIT icon
1148
Alight
ALIT
$386M
$222K ﹤0.01%
1,502
+242
+19% +$40.3K
KFY icon
1149
Korn Ferry
KFY
$4.48B
$222K ﹤0.01%
3,300
+138
+4% +$8.87K
CRNX icon
1150
Crinetics Pharmaceuticals
CRNX
$9B
$221K ﹤0.01%
+4,930
New +$228K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.